130 related articles for article (PubMed ID: 8255070)
1. [Therapeutic efficacy of a benzoxazinorifamycin, KRM-1648, administered at the different periods of infection in Mycobacterium intracellulare--infected mice].
Tomioka H; Sato K; Saito H; Hidaka T
Kekkaku; 1993 Oct; 68(10):631-5. PubMed ID: 8255070
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic efficacy of a benzoxazinorifamycin, KRM-1648, in Mycobacterium intracellulare infection induced in mice].
Saito H; Tomioka H; Sato K; Hidaka T
Kekkaku; 1994 Feb; 69(2):59-63. PubMed ID: 8126989
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic efficacy of a benzoxazinorifamycin, KRM-1648, administered in various frequencies per week in Mycobacterium intracellulare-infected mice].
Tomioka H; Sato K; Saito H; Dekio S; Hidaka T
Kekkaku; 1993 Nov; 68(11):683-6. PubMed ID: 8264123
[TBL] [Abstract][Full Text] [Related]
4. [In vivo activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin, or combination of KRM-1648 with diclofenac sodium against Mycobacterium avium infection induced in mice].
Akaki T; Sato K; Shimizu T; Tomioka H; Kawahara S
Kekkaku; 1997 Aug; 72(8):491-7. PubMed ID: 9293712
[TBL] [Abstract][Full Text] [Related]
5. [Effects of half-sized secretory leukocyte protease inhibitor and Chinese traditional medicines, yokuinin and mao-bushi-saishin-to, on therapeutic efficacies of benzoxazinorifamycin KRM-1648 against Mycobacterium avium complex infection induced in mice].
Sato K; Shimizu T; Tomioka H; Kawahara S
Kekkaku; 1998 Aug; 73(8):501-6. PubMed ID: 9780605
[TBL] [Abstract][Full Text] [Related]
6. [Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols].
Tomioka H; Saito H
Kekkaku; 1994 Nov; 69(11):703-10. PubMed ID: 7837724
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic efficacy of a benzoxazinorifamycin, KRM-1648, combined with a immunopotentiator, LC9018, in Mycobacterium intracellulare infection induced in beige mice].
Tomioka H; Sato K; Saito H; Hidaka T
Kekkaku; 1993 Dec; 68(12):751-4. PubMed ID: 8301917
[TBL] [Abstract][Full Text] [Related]
8. [Chemoprophylaxis against Mycobacterium avium complex infection induced in mice].
Saito H; Murakami K; Kobayashi K; Gidoh M; Hidaka T; Kwon HH
Kekkaku; 1999 Sep; 74(9):677-81. PubMed ID: 10535281
[TBL] [Abstract][Full Text] [Related]
9. [Profiles of expression of the therapeutic efficacy of KRM-1648 in mice infected with Mycobacterium avium complex at different challenge doses].
Shimizu T; Ogasawara K; Sato K; Sano C; Tomioka H
Kekkaku; 2001 May; 76(5):413-8. PubMed ID: 11449696
[TBL] [Abstract][Full Text] [Related]
10. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
Tomioka H; Sato K; Saito H
Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with glycyrrhizin against Mycobacterium avium complex infection in mice].
Shimizu T; Tomioka H; Sato K; Akaki T; Ogasawara K; Kawahara S
Kekkaku; 1999 Aug; 74(8):617-21. PubMed ID: 10487030
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic efficacy of benzoxazinorifamycin KRM-1648 against experimental murine tuberculosis: (1). A study on the efficacy of short course treatment with the intratracheal and intravenous infection model].
Doi N
Kekkaku; 1998 Feb; 73(2):53-64. PubMed ID: 9545697
[TBL] [Abstract][Full Text] [Related]
13. [Mechanism of bacterial regrowth at the sites of infection in Mycobacterium avium complex-infected mice during treatment with chemotherapeutic agents].
Sato K; Tomioka H; Maw WW; Saito H
Kekkaku; 1995 Dec; 70(12):673-8. PubMed ID: 8551714
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice].
Nakanaga K; Saito H; Ishii N; Goto M
Kekkaku; 2004 May; 79(5):333-9. PubMed ID: 15211873
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice.
Tomioka H; Saito H; Sato K; Yamane T; Yamashita K; Hosoe K; Fujii K; Hidaka T
Antimicrob Agents Chemother; 1992 Feb; 36(2):387-93. PubMed ID: 1605603
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of benzoxazinorifamycin, KRM-1648, in combination with other antimicrobials against Mycobacterium leprae infection induced in nude mice.
Saito H; Tomioka H; Sato K; Dekio S
Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):43-7. PubMed ID: 8189088
[TBL] [Abstract][Full Text] [Related]
17. In vivo antileprosy activity of the newly synthesized benzoxazinorifamycin, KRM-1648.
Tomioka H; Saito H
Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):255-8. PubMed ID: 8371034
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic efficacy of kanamycin and clofazimine combined with muramyl dipeptide against Mycobacterium intracellulare infection induced in mice].
Tomioka H; Sato K; Saito H
Kekkaku; 1991 Dec; 66(12):811-7. PubMed ID: 1784098
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis.
Hirata T; Saito H; Tomioka H; Sato K; Jidoi J; Hosoe K; Hidaka T
Antimicrob Agents Chemother; 1995 Oct; 39(10):2295-303. PubMed ID: 8619585
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of in vivo therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, in SCID mouse model for disseminated Mycobacterium avium complex infection.
Emori M; Tomioka H; Sato K; Saito H
Int J Antimicrob Agents; 1998 Apr; 10(1):59-65. PubMed ID: 9624545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
